LCZ Plus New Tablet is a combination medication containing Chlorpheniramine Maleate (2mg), Paracetamol (500mg), and Phenylephrine (10mg), formulated to provide effective relief from symptoms associated with common cold, allergic rhinitis, and sinusitis. Chlorpheniramine Maleate, an antihistamine, helps alleviate allergic symptoms such as sneezing, runny nose, and watery eyes by blocking histamine H1 receptors. Paracetamol acts as an analgesic and antipyretic, reducing fever and relieving mild to moderate pain including headaches, muscle aches, and sore throat commonly experienced during upper respiratory tract infections. Phenylephrine, a selective alpha-1 adrenergic receptor agonist, serves as a decongestant by constricting nasal blood vessels, thereby reducing nasal congestion and improving nasal airflow. The combined action of these active ingredients makes LCZ Plus New Tablet suitable for symptomatic management of cold and allergy-related conditions. It is important to use this medication as directed by a healthcare professional and to be cautious in patients with hypertension, cardiovascular diseases, or thyroid disorders due to the vasoconstrictive effects of Phenylephrine. LCZ Plus New Tablet should be avoided in individuals with known hypersensitivity to any component of the formulation. Proper dosage adherence and consultation with a physician are recommended to ensure safety and efficacy.